1. Home
  2. MVBF vs BWAY Comparison

MVBF vs BWAY Comparison

Compare MVBF & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$28.11

Market Cap

333.7M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$17.82

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVBF
BWAY
Founded
1997
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.7M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MVBF
BWAY
Price
$28.11
$17.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$27.60
$23.50
AVG Volume (30 Days)
68.7K
64.0K
Earning Date
10-29-2025
11-11-2025
Dividend Yield
2.52%
N/A
EPS Growth
73.99
213.09
EPS
2.45
0.13
Revenue
$167,853,000.00
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
$14.06
$22.24
P/E Ratio
$11.01
$56.10
Revenue Growth
18.75
27.08
52 Week Low
$15.59
$7.84
52 Week High
$28.37
$18.18

Technical Indicators

Market Signals
Indicator
MVBF
BWAY
Relative Strength Index (RSI) 68.52 64.62
Support Level $26.52 $16.75
Resistance Level $27.47 $18.06
Average True Range (ATR) 0.63 0.82
MACD 0.10 0.22
Stochastic Oscillator 97.29 92.96

Price Performance

Historical Comparison
MVBF
BWAY

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: